Archives of Medical Laboratory Sciences

Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Springer. 2020 Mar 1;63(3):457–60.

Wang L, Wang Y, Ye D, agents QL-I journal of antimicrobial, 2020 undefined. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Elsevier.

Zimmermann P, journal NC-TP infectious disease, 2020 undefined. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in. ncbi.nlm.nih.gov.

Lai C, Shih T, Ko W, Tang H, of PH-I journal, 2020 undefined. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Elsevier.

pediatrics SP-C and experimental, 2020 undefined. Epidemiology, virology, and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). ncbi.nlm.nih.gov.

Ganji A, Mosayebi G, … MK-J of AU, 2020 undefined. A Review of the 2019 Novel Coronavirus (Covid-19): Immunopathogenesis, Molecular Biology and Clinical Aspects. jams.arakmu.ac.ir.

Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. Vol. 92, Journal of Medical Virology. John Wiley and Sons Inc.; 2020. p. 491–4.

Li S, Fu B, Meshram C. Innate immune and inflammatory responses to respiratory viruses. 2019;

Dee Gunn Kaifeng Lisa Lin M, Suzuki Y, Nakano H. Pathology and Mortality Influenza-Induced Pulmonary Immune and Exudate Macrophages Produce Monocyte-Derived Dendritic Cells + CCR2. J Immunol References. 2008;180:2562–72.

Mcgill J, Heusel JW, Legge KL. Innate immune control and regulation of influenza virus infections. J Leukoc Biol. 2009 Oct;86(4):803–12.

Damjanovic D, Divangahi M, … KK-TA journal of, 2011 undefined. Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection. Elsevier.

Wang S, Qu X, oncology RZ hematology &, 2012 undefined. Clinical applications of mesenchymal stem cells. jhoonline.biomedcentral.com.

Murphy M, Moncivais K, molecular AC-E&, 2013 undefined. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. nature.com.

Uccelli A, Pistoia V, immunology LM-T in, 2007 undefined. Mesenchymal stem cells: a new strategy for immunosuppression? Elsevier.

Jiang X, Zhang Y, Liu B, Zhang S, Wu Y, Blood XY-, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. ashpublications.org.

Ramasamy R, Fazekasova H, Lam E, … IS-, 2007 undefined. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. journals.lww.com.

Nauta A, Westerhuis G, Kruisselbrink A, Blood EL-, 2006 undefined. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. ashpublications.org.

Spaggiari G, Blood AC-, Journal T, 2008 undefined. Mesenchymal stem cells inhibit natural killer–cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2, 3-dioxygenase and prostaglandin E2. ashpublications.org.

Spaggiari G, Capobianco A, Becchetti S, Blood MM-, 2006 undefined. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell. ashpublications.org.

Jin HJ, Bae YK, Kim M, Kwon S-J, Bae Jeon H, Choi SJ, et al. Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy. Int J Mol Sci. 2013;14:17986–8001.

The immunomodulatory effects of mesenchymal stem cells on long term pulmonary complications in an animal model exposed to a sulfur mustard analog. Elsevier.

Leng Z, Zhu R, Hou W, Feng Y, Yang Y, … QH-A and, et al. Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. ncbi.nlm.nih.gov.

Bassey B, Chaos JA-, Fractals S&, 2021 undefined. Global stability analysis of the role of multi-therapies and non-pharmaceutical treatment protocols for COVID-19 pandemic. Elsevier.

Serin I, Sari N, Dogu M, Acikel S, … GB-J of I and, 2020 undefined. A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality. Elsevier.

Alharbi S, Almutairi A, Jan A, Cureus AA-, 2020 undefined. Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies. ncbi.nlm.nih.gov.

Bussani R, Schneider E, Zentilin L, Collesi C, EBioMedicine HA-, 2020 undefined. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. Elsevier.

Gasparello J, Finotti A, hypotheses RG-M, 2021 undefined. Tackling the COVID-19 “cytokine storm” with microRNA mimics directly targeting the 3’UTR of pro-inflammatory mRNAs. Elsevier.

Meftahi G, Jangravi Z, Sahraei H, Research ZB-I, 2020 undefined. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging.” Springer.

Kasteren P van, … B van DV-J of C, 2020 undefined. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. Elsevier.

AlJame M, Ahmad I, Imtiaz A, Medicine AM-I in, 2020 undefined. Ensemble learning model for diagnosing COVID-19 from routine blood tests. Elsevier.

Liao D, Zhou F, Luo L, Xu M, Wang H, … JX-TL, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Elsevier.

Mak G, Cheng P, Lau S, … KW-J of C, 2020 undefined. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. Elsevier.

Peng J, Qi | Di, Yuan G, Deng | Xinyu, Mei Y, Feng L, et al. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study. J Clin Lab Anal. 2020 Oct 1;34(10).

Frater J, Zini G, … G d’Onofrio-I journal of, 2020 undefined. COVID‐19 and the clinical hematology laboratory. Wiley Online Library. 2020 Jun 1;42(S1):11–8.

Mishal A, Saravanan R, Atchitha SS, Santhiya K, Rithika... - Google Scholar [Internet]. [cited 2021 Feb 15]. Available from: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Mishal+A%2C+Saravanan+R%2C+Atchitha+SS%2C+Santhiya+K%2C+Rithika+M%2C+Menaka+SS%2C+et+al.+A+Review+of+Corona+Virus+Disease-2019.+History.+2020%3B4%3A07.&btnG=

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Elsevier.

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status. Vol. 7, Military Medical Research. BioMed Central Ltd.; 2020.

Yu Z, Ellahi R, Nutini A, Sohail A, Liquids SS-J of M, 2020 undefined. Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection. Elsevier.

Alsharidah S, Ayed M, Ameen R, … FA-IJ of, 2021 undefined. COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study. Elsevier.

Pushparajah D, Jimenez S, Wong S, … HA-A drug delivery, 2021 undefined. Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Elsevier.

Regmi S, Pathak S, Kim J, … CY-E journal of cell, 2019 undefined. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives. Elsevier.

Xu J, Lian W, Chen J, Li W, Li L, Huang Z. Chemical-defined medium supporting the expansion of human mesenchymal stem cells. Stem Cell Research and Therapy. 2020 Mar 19;11(1).

Ren G, Zhang L, Zhao X, Xu G, Zhang Y, cell AR-C stem, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Elsevier.

Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Blood TN-, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. ashpublications.org.

English K, Barry FP, Mahon BP. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunology Letters. 2008;115:50–8.

Wang Y, Chen X, Cao W, immunology YS-N, 2014 undefined. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. nature.com.

Corcione A, Benvenuto F, Ferretti E, Blood DG-, 2006 undefined. Human mesenchymal stem cells modulate B-cell functions. ashpublications.org.

Liu J, Liu Q, Immunology XC-F in, 2020 undefined. The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells. ncbi.nlm.nih.gov.

Chen X, Cai C, Xu D, Liu Q, Zheng S, Liu L, et al. Human mesenchymal stem cell-treated regulatory CD23+ CD43+ B cells alleviate intestinal inflammation. ncbi.nlm.nih.gov.

Chao K, Zhang S, Qiu Y, Chen X, … XZ-SCR&, 2016 undefined. Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells. Springer.

Salari V, Mengoni F, Gallo F Del, Bertini G, Fabene PF. Molecular Sciences The Anti-Inflammatory Properties of Mesenchymal Stem Cells in Epilepsy: Possible Treatments and Future Perspectives. mdpi.com.

Harrell C, Sadikot R, Pascual J, … CF-S cells, 2019 undefined. Mesenchymal stem cell-based therapy of inflammatory lung diseases: current understanding and future perspectives. hindawi.com.

Orleans L, physician H is V-P, 2020 undefined. Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill Patients with COVID-19: the case for compassionate. asipp.worldsecuresystems.com.

Wu J, Song D, Li Z, Guo B, Xiao Y, Liu W, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. nature.com.

Shu L, Niu C, Li R, Huang T, Wang Y, Huang M, et al. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Research and Therapy. 2020 Aug 18;11(1).

Feng Y, Huang J, Wu J, Xu Y, Chen B, … LJ-C, et al. Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study. Wiley Online Library. 2020 Dec 1;53(12).

Guo Z, Chen Y, Luo X, He X, Zhang Y, Wang J. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia. Vol. 24, Critical Care. BioMed Central; 2020.

Zhu Y, Zhu R, Liu K, Li X, Chen D, … DB-I and D, et al. Human umbilical cord mesenchymal stem cells for adjuvant treatment of a critically ill COVID-19 patient: A case report. ncbi.nlm.nih.gov.

Liang B, Chen J, Li T, Wu H, Yang W, Li Y, et al. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report. ncbi.nlm.nih.gov.

Xu Z, Shi L, Wang Y, Zhang J, … LH-TL respiratory, 2020 undefined. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. thelancet.com.

Dinh P, Paudel D, Brochu H, … KP-N, 2020 undefined. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. nature.com [Internet]. [cited 2021 Jul 29]; Available from: https://www.nature.com/articles/s41467-020-14344-7

Chen YS, Lin EY, Chiou TW, Harn HJ. Exosomes in clinical trial and their production in compliance with good manufacturing practice. Tzu Chi Medical Journal. 2020 Apr 1;32(2):113–20.

Muraca M, Pessina A, Pozzobon M, … MD-J of C, 2020 undefined. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? Elsevier [Internet]. [cited 2021 Jul 29]; Available from: https://www.sciencedirect.com/science/article/pii/S0168365920303710

Moll G, Drzeniek N, Kamhieh-Milz J, Geissler S, Volk HD, Reinke P. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy. Frontiers in Immunology. 2020 May 19;11.

Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, et al. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. Wiley Online Library. 2021 May 1;10(5):660–73.